Further Information
SPINT2, serine peptidase inhibitor, Kunitz type, 2, DIAR3, FLJ45571, HAI-2, HAI2, Kop, PB, hepatocyte growth factor activator inhibitor type 2, placental bikunin, serine protease inhibitor, Kunitz type, 2
Peptide ELISA: antibody detection limit dilution 1:1000.Western Blot:Approx 20kDa band observed in Human Placenta lysates (calculated MW of 21.8kDa according to NP_001159575.1). Recommended concentration: 1-3ug/ml.
- Sivagnanam M, Janecke AR, Müller T, Heinz-Erian P, Taylor S, Bird LM, Case of syndromic tufting enteropathy harbors SPINT2 mutation seen in congenital sodium diarrhea.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Rat, Mouse, Dog, Cow
The immunogen for this antibody is: C-SGDDKEQLVKNT
10653
serine peptidase inhibitor, Kunitz type, 2
SPINT2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 20kDa
NP_066925.1, NP_001159575.1
10863909
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer,Signal Transduction,Cancer Signal Transduction Membrane Membrane
This antibody is expected to recognize to recognize both reported isoforms (NP_066925.1; NP_001159575.1).
O43291